In Billing
Feb 7th, 2019
The Centers for Medicare & Medicaid Services (CMS) is proposing to change the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for 2020 and it could affect a medical group or facility’s bottom line. CLIA Analyte Additions The notice of proposed rulemaking includes the addition and deletion of analytes – or the components being studied – ...
Aug 11th, 2014
The Centers for Medicare & Medicaid Services announced August 7 in a decision memo for coverage of transcatheter mitral valve repair (TMVR) that “there is promising but inconclusive evidence whether TMVR improves health outcomes for a defined subset of the Medicare population.” In light of a national coverage analysis, initiated November 2013, CMS will cover ...
In Coding
Mar 3rd, 2014
The Centers for Medicare & Medicaid Services (CMS) has removed the coverage of evidence (CED) requirement in the national coverage determination (NCD) for fluorodeoxyglucose (FDG) positron emission tomography (PET) for solid tumors, effective June 11, 2013. CMS will cover three FDG PET scans (without the CED requirement) when used to guide subsequent management of anti-tumor ...
Feb 3rd, 2014
In a decision memo released Jan. 9, the Centers for Medicare & Medicaid Services (CMS) announced its national coverage determination for percutaneous image-guided lumbar decompression (PILD) for lumbar spinal stenosis (LSS). PILD for LSS remains a non-covered service for Medicare beneficiaries. However, CMS will cover the procedure for Medicare patients with LSS when performed in ...
In Billing
Aug 9th, 2012
In a final decision memo, the Centers for Medicare & Medicare Services (CMS) says there is insufficient evidence that autologous platelet-rich plasma (PRP) improves health outcomes in individuals with chronic diabetic, pressure, and/or venous wounds. PRP used to treat chronic non-healing diabetic, pressure, and/or venous wounds may be covered under Medicare only when the beneficiary ...